These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 25576184

  • 1. Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death.
    Domin H, Jantas D, Śmiałowska M.
    Neurochem Int; 2015 Sep; 88():110-23. PubMed ID: 25576184
    [Abstract] [Full Text] [Related]

  • 2. Presynaptic mGlu7 receptors control GABA release in mouse hippocampus.
    Summa M, Di Prisco S, Grilli M, Usai C, Marchi M, Pittaluga A.
    Neuropharmacology; 2013 Mar; 66():215-24. PubMed ID: 22564442
    [Abstract] [Full Text] [Related]

  • 3. The effects of metabotropic glutamate receptor 7 allosteric agonist N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride on developmental sevoflurane neurotoxicity: role of extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase signaling pathway.
    Wang WY, Wang H, Luo Y, Jia LJ, Zhao JN, Zhang HH, Ma ZW, Xue QS, Yu BW.
    Neuroscience; 2012 Mar 15; 205():167-77. PubMed ID: 22244976
    [Abstract] [Full Text] [Related]

  • 4. The neuroprotective effects of orthosteric agonists of group II and III mGluRs in primary neuronal cell cultures are dependent on developmental stage.
    Jantas D, Gręda A, Gołda S, Korostyński M, Lasoń W.
    Neuropharmacology; 2016 Dec 15; 111():195-211. PubMed ID: 27600687
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective effects of mGluR II and III activators against staurosporine- and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism involving inhibition of AIF translocation.
    Jantas D, Greda A, Leskiewicz M, Grygier B, Pilc A, Lason W.
    Neurochem Int; 2015 Sep 15; 88():124-37. PubMed ID: 25661514
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands.
    Gawel K, Jenda-Wojtanowska M, Gibula-Bruzda E, Kedzierska E, Filarowska J, Marszalek-Grabska M, Wojtanowski KK, Komsta L, Talarek S, Kotlinska JH.
    Physiol Behav; 2018 Mar 01; 185():112-120. PubMed ID: 29294304
    [Abstract] [Full Text] [Related]

  • 10. New evidences for a role of mGluR7 in astrocyte survival: Possible implications for neuroprotection.
    Jantas D, Lech T, Gołda S, Pilc A, Lasoń W.
    Neuropharmacology; 2018 Oct 01; 141():223-237. PubMed ID: 30170084
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Early anesthetic preconditioning in mixed cortical neuronal-glial cell cultures subjected to oxygen-glucose deprivation: the role of adenosine triphosphate dependent potassium channels and reactive oxygen species in sevoflurane-induced neuroprotection.
    Velly LJ, Canas PT, Guillet BA, Labrande CN, Masmejean FM, Nieoullon AL, Gouin FM, Bruder NJ, Pisano PS.
    Anesth Analg; 2009 Mar 01; 108(3):955-63. PubMed ID: 19224809
    [Abstract] [Full Text] [Related]

  • 13. Metabotropic glutamate 7 receptor agonist AMN082 inhibits glutamate release in rat cerebral cortex nerve terminal.
    Wang CC, Kuo JR, Huang SK, Wang SJ.
    Eur J Pharmacol; 2018 Mar 15; 823():11-18. PubMed ID: 29378190
    [Abstract] [Full Text] [Related]

  • 14. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.
    Pałucha-Poniewiera A, Brański P, Lenda T, Pilc A.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):1066-74. PubMed ID: 20562216
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.
    Domin H, Gołembiowska K, Jantas D, Kamińska K, Zięba B, Smiałowska M.
    Neurotox Res; 2014 Jul 01; 26(1):99-113. PubMed ID: 24402869
    [Abstract] [Full Text] [Related]

  • 17. Neuropeptide Y Y2 and Y5 receptors as promising targets for neuroprotection in primary neurons exposed to oxygen-glucose deprivation and in transient focal cerebral ischemia in rats.
    Domin H, Przykaza Ł, Jantas D, Kozniewska E, Boguszewski PM, Śmiałowska M.
    Neuroscience; 2017 Mar 06; 344():305-325. PubMed ID: 28057538
    [Abstract] [Full Text] [Related]

  • 18. Effects of TRH and its analogues on primary cortical neuronal cell damage induced by various excitotoxic, necrotic and apoptotic agents.
    Jantas D, Jaworska-Feil L, Lipkowski AW, Lason W.
    Neuropeptides; 2009 Oct 06; 43(5):371-85. PubMed ID: 19666192
    [Abstract] [Full Text] [Related]

  • 19. AMN082, a metabotropic glutamate receptor 7 allosteric agonist, attenuates locomotor sensitization and cross-sensitization induced by cocaine and morphine in mice.
    Jenda M, Gawel K, Marszalek M, Komsta L, Kotlinska JH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar 03; 57():166-75. PubMed ID: 25448778
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.